Toripalimab Not Yet Recruiting Phase 2 Trials for Neoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell Carcinoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04118855Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma